A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)
AstraZeneca
AstraZeneca
National University Hospital, Singapore
Jiangsu Hansoh Pharmaceutical Co., Ltd.
BeiGene
Eli Lilly and Company
Western Regional Medical Center
Hoffmann-La Roche
National University Hospital, Singapore
University of Arizona
Merck Sharp & Dohme LLC
Mirati Therapeutics Inc.
Dartmouth-Hitchcock Medical Center
Memorial Sloan Kettering Cancer Center
Emory University
Azaya Therapeutics, Inc.
Case Comprehensive Cancer Center